Position in ASRT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,906
New position
Shares Held
100
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $325,796 across 7 Drug Manufacturers - Specialty & Generic names. ASRT ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,630 | $192,682 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
188 | $111,480 | |
| 3 | VTRS |
Viatris Inc
|
945 | $12,766 | |
| 4 | HLN |
Haleon plc
|
480 | $4,804 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
100 | $1,959 | |
| 6 | ASRT |
Assertio Holdings, Inc.
This page
|
100 | $1,906 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
37 | $199 |
All Filings in ASRT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,906 | 100 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||